| View |
|
DR-XY38014
|
Onglyza
|
Saxagliptin (As Hydrochloride)
|
2.5 mg
|
Film-Coated Tablet
|
-
|
AstraZeneca Pharmaceuticals LP
|
U.S.A.
|
-
|
01 February 2021
|
04 March 2026
|
| View |
|
DR-XY38015
|
Onglyza
|
Saxagliptin (As Hydrochloride)
|
5 mg
|
Film-Coated Tablet
|
-
|
AstraZeneca Pharmaceuticals LP
|
U.S.A.
|
-
|
27 January 2021
|
04 March 2026
|
| View |
DR-XY38016_PI_01.pdf
|
DR-XY38016
|
Olmesartan medoxomil + Amlodipine (as besilate)
|
Alzor CCB
|
40mg/5mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker/ Antihypertensive
|
Ajanta Pharma Limited
|
India
|
Renewal
|
16 April 2024
|
27 May 2029
|
| View |
DR-XY38017_PI_01.pdf
|
DR-XY38017
|
Olmesartan medoxomil + Amlodipine (as besilate)
|
Alzor CCB
|
40mg/10mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker/ Calcium Channel Blocker/ Antihypertensive
|
Ajanta Pharma Limited
|
India
|
Renewal
|
07 April 2024
|
27 May 2029
|
| View |
|
DR-XY38026
|
Gabapentin
|
Reinin
|
600 mg
|
Tablet
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
09 September 2020
|
21 June 2025
|
| View |
|
DR-XY38029
|
Metformin Hydrochloride + Glimepiride
|
Azulix 1 MF
|
500mg / 1mg
|
Tablet
|
Oral Hypoglycemic (Biguanide and Sulfonylurea)
|
Torrent Pharmaceuticals Ltd.
|
India
|
Initial (from Monitored Release)
|
30 May 2022
|
01 June 2025
|
| View |
|
DR-XY38036
|
Cefixime (As Trihydrate)
|
C-Tax P
|
50mg/5mL
|
Oral Powder For Suspension
|
-
|
Emcure Pharmaceuticals Ltd.
|
India
|
-
|
19 June 2020
|
02 June 2025
|
| View |
|
DR-XY38038
|
Betahistine Hydochloride
|
Betavert
|
16 mg
|
Film-Coated Tablet
|
Antivertigo preparation
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
23 July 2020
|
05 August 2025
|
| View |
|
DR-XY38041
|
Amoxicillin (As Trihydrate)
|
Spectra
|
100mg/mL
|
Powder for Suspension (Oral Drops)
|
ANTIBACTERIAL (PENICILLIN)
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
22 June 2023
|
05 August 2028
|
| View |
|
DR-XY38042
|
Glipizide
|
Glipdin
|
5 mg
|
Tablet
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
-
|
25 June 2020
|
03 June 2025
|
| View |
|
DR-XY38044
|
Amlodipine (As Besilate)
+
Hydrochlorothiazide
|
Amvasc Plus
|
10 mg/12.5 mg
|
Tablet
|
-
|
Amherst Laboratories Inc.
|
Philippines
|
Automatic Renewal (Correction)
|
23 September 2022
|
02 June 2025
|
| View |
|
DR-XY380444
|
Amlodipine (As Besilate)
+
Hydrochlorothiazide
|
Amvasc Plus
|
10 mg/12.5 mg
|
Tablet
|
-
|
Amherst Laboratories Inc.
|
Philippines
|
-
|
05 August 2020
|
02 June 2025
|
| View |
|
DR-XY38045
|
Amlodipine (As Besilate)
+
Hydrochlorothiazide
|
Amvasc Plus
|
5 mg/12.5 mg
|
Tablet
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
07 April 2020
|
02 June 2025
|
| View |
|
DR-XY38046
|
Doxofylline
|
None
|
400 mg
|
Tablet
|
Drug for Obstructive Airway Diseases (Xanthine)
|
Amherst Laboratories, Inc.
|
Philippines
|
Initial (from Monitored Release Extension)
|
25 April 2022
|
21 June 2025
|
| View |
|
DR-XY38053
|
Retinol Palmitate
|
Retimax
|
200,000 IU
|
Softgel Capsule
|
-
|
Olive Healthcare
|
India
|
-
|
20 April 2020
|
07 June 2025
|
| View |
|
DR-XY38057
|
Montelukast (As Sodium)
|
Montekast
|
5 mg
|
Chewable Tablet
|
-
|
Taiwan Biotech Co., Ltd.
|
Taiwan
|
-
|
27 April 2020
|
04 June 2025
|
| View |
|
DR-XY38062
|
Zolendronic Acid
|
Zoletalis
|
4mg/mL
|
Solution for injection ( IV Infusion)
|
Biphosphonate
|
Vitalis S.A.C.I.
|
Colombia
|
-
|
20 October 2021
|
14 January 2025
|
| View |
|
DR-XY38063
|
Cefaclor (As Monohydrate)
|
Andrecep
|
250 mg/5 mL
|
Granules For Suspension
|
-
|
Lloyd laboratories, Inc.
|
Philippines
|
-
|
28 September 2020
|
07 June 2025
|
| View |
DR-XY38071_PI_01.pdf
|
DR-XY38071
|
Testosterone enantate
|
Vivrone
|
250mg/mL
|
Solution For Injection (IM)
|
-
|
Geofman Pharmaceuticals
|
Pakistan
|
Initial from Monitored Release Extension (MRE)]
|
14 August 2023
|
09 June 2025
|
| View |
|
DR-XY38072
|
Ketotifen Fumarate
|
Privent
|
0.05% w/v
|
Ophthalmic Solution
|
-
|
Micro Labs Limited
|
India
|
Automatic Renewal
|
10 November 2021
|
07 June 2025
|